Jacopo Leonardi - 01 Jun 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Pres., Global Commercial Ops
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Jun 2022, 18:07:38 UTC
Previous filing
18 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Award $0 +44,466 $0.000000 44,466 01 Jun 2022 Ordinary shares 44,466 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2 The shares subject to the restricted stock units vest ratably over three years on each anniversary of the grant date (June 1, 2022).